Generics - Teva Pharmaceutical Industries

Filter

Popular Filters

76 to 100 of 108 results

US FTC goes after Pharma on two fronts relating to patent agreements

14-08-2012

In what appears to be a two pronged attack on pharmaceutical industry practices, the US Federal Trade…

Effexor XRGenericsLegalNorth AmericaPatentsPfizerPharmaceuticalTeva Pharmaceutical IndustriesWyeth

Johnson & Johnson close to settling over Risperdal marketing; SEC probes Teva

06-08-2012

US health care giant Johnson & Johnson (NYSE: JNJ) has reached "an agreement in principle'' with the…

FinancialGenericsInvegaJanssenJohnson & JohnsonLegalMarkets & MarketingNatrecorNorth AmericaPharmaceuticalRisperdalTeva Pharmaceutical Industries

Teva's EPS rockets, helped by higher sales in USA

03-08-2012

Israel-based Teva Pharmaceutical Industries (NYSE: TEVA), the world's largest generic drugs producer…

CephalonFinancialGenericsManagementPharmaceuticalTeva Pharmaceutical Industries

EU Commission focus now on Servier and others re-perindopril antitrust issues

31-07-2012

The European Commission has informed French independent pharmaceutical company Servier and several of…

Cardio-vascularEuropeGenericsLegalMarkets & MarketingMylan LaboratoriesPatentsperindoprilPharmaceuticalServierTeva Pharmaceutical Industries

US Court confirms Pfizer patents on Lyrica valid through 2018

23-07-2012

The US District Court for the District of Delaware upheld the Pfizer (NYSE: PFE) composition of matter…

GenericsLegalLyricaNeurologicalNorth AmericaPatentsPfizerPharmaceuticalTeva Pharmaceutical Industries

USA FDA approves ANDAs for Plan B One-Step and Trandate

16-07-2012

Watson Pharmaceuticals (NYSE: WPI) says its subsidiary Watson Laboratories approval from the US Food…

Cardio-vascularGenericsNorth AmericaPar PharmaceuticalsPlan B One-StepRegulationReproductiveTeva Pharmaceutical IndustriesTrandateWatson Pharmaceuticals

Teva gets favorable UK Copaxone patent ruling

12-07-2012

Israel-based Teva Pharmaceutical Industries (Nasdaq: TEVA) says that the UK High Court of Justice issued…

CopaxoneEuropeGenericsLegalMylan LaboratoriesNeurologicalPatentsPharmaceuticalTeva Pharmaceutical Industries

Novartis and Teva announce expansion plans in Russia

05-07-2012

Swiss drug major Novartis (NOVN: VX) has signed an agreement with RT-Biotechprom, one of Russia's largest…

EuropeFinancialGenericsMarkets & MarketingNovartisPharmaceuticalRT-BiotechpromTeva Pharmaceutical Industries

Teva launches copy version of Difflam in the UK

14-06-2012

The UK subsidiary of Israeli generics giant Teva Pharmaceutical Industries (Nadaq: TEVA) has announced…

DifflamEuropeGenericsMarkets & MarketingMeda PharmaceuticalsNeurologicalOroezeTeva Pharmaceutical Industries

Mylan settles Provigil litigation with Teva

10-06-2012

US generic major Mylan (Nasdaq: MYL) says that its subsidiary Mylan Pharmaceuticals has resolved all…

CephalonFinancialGenericsLegalMylan LaboratoriesNeurologicalNorth AmericaProvigilTeva Pharmaceutical Industries

FDA delays once-a-day Prezista approval; finds counterfeit of Teva's Adderall

30-05-2012

US health care giant Johnson & Johnson's (NYSE: JNJ) Janssen Therapeutics division has received a complete…

AdderallAnti-viralsGenericsJanssenJohnson & JohnsonMarkets & MarketingNeurologicalNorth AmericaPharmaceuticalPrezistaRegulationTeva Pharmaceutical Industries

Teva lowers full-year 2012 forecasts

25-05-2012

Israel-based generic drug major Teva Pharmaceutical Industries (Nasdaq: TEVA) has provided its current…

FinancialGenericsPharmaceuticalTeva Pharmaceutical Industries

Israel'sTeva beats expectations with 40% leap in profit

09-05-2012

Israel-headquartered Teva Pharmaceutical Industries (Nasdaq: TEVA) has reported a robust set of first-quarter…

CephalonFinancialGenericsPharmaceuticalTeva Pharmaceutical Industries

Exec appointments at Novo Nordisk and Teva

09-05-2012

Danish insulin giant Novo Nordisk (NOV: N) says that former Pfizer executive Robert Clark will be joining…

GenericsManagementNovo NordiskPharmaceuticalTeva Pharmaceutical Industries

FDA decides Teva is sole first-to-file on Provigil; Mylan argues ruling

09-04-2012

Israel-based Teva Pharmaceutical Industries (Nasdaq: TEVA) said on April 5 that the US Food and Drug…

CephalonGenericsLegalModafinilMylan LaboratoriesNeurologicalNorth AmericaPar PharmaceuticalProvigilRegulationTeva Pharmaceutical Industries

Opportunities for Pharma in narcolepsy

20-02-2012

The narcolepsy therapeutics developmental pipeline is weak, with only six molecules in development, providing…

BioprojectCephalonGenericsMarkets & MarketingNeurologicalNuvigilPharmaceuticalProvigilResearchTeva Pharmaceutical IndustriesUCBXyrem

Teva Pharma strong sales growth helped by acquisitions

16-02-2012

Israel-headquartered Teva Pharmaceutical Industries (Nasdaq: TEVA) reported fourth-quarter 2011 results…

CephalonFinancialGenericsPharmaceuticalTeva Pharmaceutical Industries

76 to 100 of 108 results

Back to top